The activation of TLR9 releasing type 1 IFNs through self-DNA, including mtDNA, also increases liver inflammation in the NASH or NAFLD through increasing hepatocytes death independent of apoptosis and liver fibrosis (233). The gene discussed is TLR9; the disease is metabolic dysfunction-associated steatohepatitis.